EP0972011A4 - Proteine kinase cyclino-dependante - Google Patents

Proteine kinase cyclino-dependante

Info

Publication number
EP0972011A4
EP0972011A4 EP98906202A EP98906202A EP0972011A4 EP 0972011 A4 EP0972011 A4 EP 0972011A4 EP 98906202 A EP98906202 A EP 98906202A EP 98906202 A EP98906202 A EP 98906202A EP 0972011 A4 EP0972011 A4 EP 0972011A4
Authority
EP
European Patent Office
Prior art keywords
cyclin
cdk
disclosed
protein kinase
dependent protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98906202A
Other languages
German (de)
English (en)
Other versions
EP0972011A1 (fr
Inventor
David L Gerhold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9707491.8A external-priority patent/GB9707491D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0972011A1 publication Critical patent/EP0972011A1/fr
Publication of EP0972011A4 publication Critical patent/EP0972011A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne une molécule d'acide nucléique isolée qui code une nouvelle kinase cyclino-dépendante (CDK = cyclin-dependent kinase) humaine qui comprend une nouvelle séquence de signature du domaine de liaison de la cycline et ne présente pas plusieurs résidus d'acide aminé, qui étaient conservés jusqu'à maintenant, impliqués dans la régulation du complexe cdk/cycline. L'invention concerne des protéines et des formes mutantes biologiquement actives associées.
EP98906202A 1997-02-07 1998-02-06 Proteine kinase cyclino-dependante Withdrawn EP0972011A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3785597P 1997-02-07 1997-02-07
US37855P 1997-02-07
GBGB9707491.8A GB9707491D0 (en) 1997-04-14 1997-04-14 Cyclin-dependent protein kinase
GB9707491 1997-04-14
PCT/US1998/002337 WO1998035015A1 (fr) 1997-02-07 1998-02-06 Proteine kinase cyclino-dependante

Publications (2)

Publication Number Publication Date
EP0972011A1 EP0972011A1 (fr) 2000-01-19
EP0972011A4 true EP0972011A4 (fr) 2003-04-16

Family

ID=26311373

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98906202A Withdrawn EP0972011A4 (fr) 1997-02-07 1998-02-06 Proteine kinase cyclino-dependante

Country Status (4)

Country Link
EP (1) EP0972011A4 (fr)
JP (1) JP2001511015A (fr)
CA (1) CA2280206A1 (fr)
WO (1) WO1998035015A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1961813B1 (fr) 1998-12-16 2011-08-10 Novartis Vaccines and Diagnostics, Inc. Kinase de type humain dépendant de la cycline (hPNQALRE)
WO2000073469A2 (fr) * 1999-05-28 2000-12-07 Sugen, Inc. Proteines kinases
WO2009063175A1 (fr) * 2007-11-13 2009-05-22 The Institute Of Cancer Research; Royal Cancer Hospital Procédés pour déterminer la résistance à une thérapie contre le cancer

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI; 1 July 1995 (1995-07-01), XP002229224, Database accession no. H17727 *
DATABASE EMBL [online] EBI; 15 June 1992 (1992-06-15), XP002229248, Database accession no. x66357 *
DATABASE EMBL [online] EBI; 3 May 1993 (1993-05-03), XP002229247, Database accession no. x66362 *
DATABASE SWISS-PROT [online] EBI; 1 April 1993 (1993-04-01), XP002229225, Database accession no. P29620 *
GRANA X ET AL: "PITALRE, A NUCLEAR CDC2-RELATED PROTEIN KINASE THAT PHOSPHORYLATES THE RETINOBLASTOMA PROTEIN IN VITRO", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 91, April 1994 (1994-04-01), pages 3834 - 3838, XP000919000, ISSN: 0027-8424 *
HATA S.: "complementary DNA cloning of a novel CDC2-positive -CDC28-related protein kinase from rice", FEBS (FEDERATION OF EUROPEAN BIOECHEMICAL SOCIETIES) LETTERS, vol. 279, no. 1, 1991, pages 149 - 152, XP002229244 *
MEYERSON M ET AL: "A family of human cdc2-related protein kinases", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 11, no. 8, x66362, 1992, pages 2909 - 2917, XP002128265, ISSN: 0261-4189 *
See also references of WO9835015A1 *

Also Published As

Publication number Publication date
EP0972011A1 (fr) 2000-01-19
CA2280206A1 (fr) 1998-08-13
JP2001511015A (ja) 2001-08-07
WO1998035015A1 (fr) 1998-08-13

Similar Documents

Publication Publication Date Title
EA199900355A1 (ru) Теломераза обратная тринскриптаза
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
EP1009814A4 (fr) Tyrosine kinase receptrice, kdr
DK0506884T3 (da) Fremgangsmåde til afgivelse af molekyler til eukaryotiske celler
EP1712623A3 (fr) Sélection de protéines par fusions de proteénes et d'ARN
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
GB9722320D0 (en) Human cell cycle checkpoint proteins
WO2001057198A3 (fr) Procedes de preparation
EP1012603A4 (fr) Fragments fonctionnels de la proteine vpr vih-1 et procedes d'utilisation
HUP9900750A2 (hu) Gén kifejezésére szolgáló promóterek
EP1005539A4 (fr) PROTEINES IKK-$g(a), ACIDES NUCLEIQUES ET PROCEDES
CA2336261A1 (fr) Genes et proteines cycline e2
EP0972011A4 (fr) Proteine kinase cyclino-dependante
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
HK1046911A1 (zh) 经稳定的病毒外膜蛋白质及其使用
WO2001042287A3 (fr) Nouvelles proteines membranaires humaines et polynucleotides codant pour ces proteines
AU2001280639A1 (en) 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
EP0780472A3 (fr) Protéines de stress
WO2002012475A3 (fr) Facteur associe a c1q, polypeptides homologues et utilisations therapeutiques associees
WO2001090365A3 (fr) Nouvelles molecules de proteine kinases 13305, et leurs utilisations
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
WO2002016563A3 (fr) 14189, nouvelle kinase humaine et utilisations associees
WO2002016568A3 (fr) 46863, methyltransferase humaine, et utilisations
WO2001073050A3 (fr) 3714, 16742, 23546, et 13887 nouvelles molecules de proteine kinase et leurs utilisations
WO2001057086A3 (fr) Nouvelles proteines membranaires humaines et les polynucleotides les codant

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990907

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030304

17Q First examination report despatched

Effective date: 20030626

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031107